IFNγ signaling-Does it mean JAK-STAT?

Cytokine and Growth Factor Reviews

Volumn 19, Issue 5-6, 2008, Pages 383-394

  Gough, Daniel J ^a   Levy, David E ^a   Johnstone, Ricky W ^b   Clarke, Christopher J ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Interferon gamma; STAT1 independent

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

CELL ADHESION; CELL CYCLE ARREST; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL CYCLE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL ADHESION; CELL CYCLE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERFERON REGULATORY FACTORS; INTERFERON-GAMMA; JANUS KINASES; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1;

EID: 56949089974     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2008.08.004     Document Type: Review

References (98)

1. Isaacs A., and Lindenmann J. Virus interference I. The interferon. Proc R Soc Lond B: Biol Sci 147 (1957) 258-267
2. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189 [Epub 2003 Oct 2002]
3. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2 (2002) 850-861
4. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annu Rev Immunol 15 (1997) 749-795
5. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335 (1996) 1956-1961
6. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Blanche S., et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 100 (1997) 2658-2664
7. Doffinger R., Helbert M.R., Barcenas-Morales G., Barcenas-Morales G., Yang K., Dupuis S., et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38 (2004) e10-e14 [Epub 2003 December 2004]
8. Davies E.G., Isaacs D., and Levinsky R.J. Defective immune interferon production and natural killer activity associated with poor neutrophil mobility and delayed umbilical cord separation. Clin Exp Immunol 50 (1982) 454-460
9. Briscoe J., Rogers N.C., Witthuhn B.A., Watling D., Harpur A.G., Wilks A.F., et al. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state. EMBO J 15 (1996) 799-809
10. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
11. Decker T., Kovarik P., and Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interf Cytok Res 17 (1997) 121-134
12. Yang J., and Stark G.R. Roles of unphosphorylated STATs in signaling. Cell Res 18 (2008) 443-451
13. Zhu X., Wen Z., Xu L.Z., and Darnell Jr. J.E. STAT1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated JAK2 kinase. Mol Cell Biol 17 (1997) 6618-6623
14. Decker T., and Kovarik P. Serine phosphorylation of STATs. Oncogene 19 (2000) 2628-2637
15. Varinou L., Ramsauer K., Karaghiosoff M., Kolbe T., Pfeffer K., Muller M., et al. Phosphorylation of the STAT1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19 (2003) 793-802
16. Durbin J.E., Hackenmiller R., Simon M.C., and Levy D.E. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 84 (1996) 443-450
17. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., et al. Targeted disruption of the STAT1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431-442
18. Dupuis S., Dargemont C., Fieschi C., Thomassin N., Rosenzweig S., Harris J., et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293 (2001) 300-303
19. Picard C., and Casanova J.L. Inherited disorders of cytokines. Curr Opin Pediatr 16 (2004) 648-658
20. Gil M.P., Bohn E., O'Guin A.K., Ramana C.V., Levine B., Stark G.R., et al. Biologic consequences of STAT1-independent IFN signalling. Proc Natl Acad Sci USA 98 (2001) 6680-6685
21. Shresta S., Sharar K.L., Prigozhin D.M., Snider H.M., Beatty P.R., and Harris E. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 175 (2005) 3946-3954
22. Malmgaard L., Salazar-Mather T.P., Lewis C.A., and Biron C.A. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways. J Virol 76 (2002) 4520-4525
23. Ramana C.V., Gil M.P., Schreiber R.D., and Stark G.R. STAT1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23 (2002) 96-101
24. Qing Y., and Stark G.R. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 279 (2004) 41679-41685 [Epub 42004 July 41627]
25. Meinke A., Barahmand-Pour F., Wohrl S., Stoiber D., and Decker T. Activation of different STAT5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol Cell Biol 16 (1996) 6937-6944
26. Ramana C.V., Kumar A., and Enelow R. STAT1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of STAT3 in mouse embryonic fibroblasts. Biochem Biophys Res Commun 327 (2005) 727-733
27. Gough D.J., Sabapathy K., Ko E.Y., Arthur H.A., Schreiber R.D., Trapani J.A., et al. A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282 (2007) 938-946
28. Matsumoto M., Tanaka N., Harada H., Kimura T., Yokochi T., Kitagawa M., et al. Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem 380 (1999) 699-703
29. Zimmermann A., Trilling M., Wagner M., Wilborn M., Bubic I., Jonjic S., et al. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201 (2005) 1543-1553
30. Nguyen H., Ramana C.V., Bayes J., and Stark G.R. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 276 (2001) 33361-33368
31. Choudhury G.G. A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation. J Biol Chem 279 (2004) 27399-27409 [Epub 22004 April 27313]
32. Deb A., Haque S.J., Mogensen T., Silverman R.H., and Williams B.R. RNA-dependent protein kinase PKR is required for activation of NF-kappa B by IFN-gamma in a STAT1-independent pathway. J Immunol 166 (2001) 6170-6180
33. 2+ and CaMKII for STAT1 Ser-727 phosphorylation in response to IFN-gamma. Proc Natl Acad Sci USA 99 (2002) 5971-5976 [Epub 2002 April 5923]
34. David M., Petricoin III E., Benjamin C., Pine R., Weber M.J., and Larner A.C. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269 (1995) 1721-1723
35. Burova E., Vassilenko K., Dorosh V., Gonchar I., and Nikolsky N. Interferon gamma-dependent transactivation of epidermal growth factor receptor. FEBS Lett 581 (2007) 1475-1480
36. Takaoka A., Mitani Y., Suemori H., Sato M., Yocochi T., Noguchi S., et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 288 (2000) 2357-2360
37. Bluyssen H.A., Muzaffar R., Vlieststra R.J., van der Made A.C., Leung S., Stark G.R., et al. Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci USA 92 (1995) 5645-5649
38. Wong L.H., Hatzinisiriou I., Devenish R.J., and Ralph S.J. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. J Immunol 160 (1998) 5475-5484
39. Chang Y.J., Holtzman M.J., and Chen C.C. Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway. J Biol Chem 277 (2002) 7118-7126 [Epub 2001 December 7120]
40. Uddin S., Sher D.A., Alsayed Y., Pons S., Colamonici O.R., Fish E.N., et al. Interaction of p59fyn with interferon-activated JAK kinases. Biochem Biophys Res Commun 235 (1997) 83-88
41. Rani M.R., Hibbert L., Sizemore N., Stark G.R., and Ransohoff R.M. Requirement of phosphoinositide 3-kinase and Akt for interferon-beta-mediated induction of the beta-R1 (SCYB11) gene. J Biol Chem 277 (2002) 38456-38461 [Epub 32002 August 38456]
42. Uddin S., Majchrzak B., Wang P.C., Modi S., Khan M.K., Fish E.N., et al. Interferon-dependent activation of the serine kinase PI 3′-kinase requires engagement of the IRS pathway but not the Stat pathway. Biochem Biophys Res Commun 270 (2000) 158-162
43. Sun D., and Ding A. MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat Immunol 7 (2006) 375-381
44. Alsayed Y., Uddin S., Ahmad S., Majchrzak B., Druker B.J., Fish E.N., et al. IFN-gamma activates the C3G/Rap1 signaling pathway. J Immunol 164 (2000) 1800-1806
45. Kawai T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
46. Hu J., Roy S.K., Shapiro P.S., Rodig S.R., Reddy S.P., Platanias L.C., et al. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem 276 (2001) 287-297
47. Xia K., Mukhopadhyay N.K., Inhorn R.C., Barber D.L., Rose P.E., Lee R.S., et al. The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc Natl Acad Sci USA 93 (1996) 11681-11686
48. Roy S.K., Hu J., Meng Q., Xia Y., Shapiro P.S., Reddy S.P., et al. MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 99 (2002) 7945-7950
49. Halfter U.M., Derbyshire Z.E., and Vaillancourt R.R. Interferon-gamma-dependent tyrosine phosphorylation of MEKK4 via Pyk2 is regulated by annexin II and SHP2 in keratinocytes. Biochem J 388 (2005) 17-28
50. Ramsauer K, Sadzak I, Porras A, Pilz A, Nebreda AR, Decker T, et al. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 2002;99:12859-64 [Epub 12002 September 12813].
51. Platanias L.C. Mechanisms of Type-I- and Type-II-interferon-mediated signalling. Nat Rev Immunol 5 (2005) 375
52. Valledor A.F., Sanchez-Tillo E., Arpa L., Park J.M., Caelles C., Lloberas J., et al. Selective roles of MAPKs during the macrophage response to IFN-gamma. J Immunol 180 (2008) 4523-4529
53. Giroux M., Schmidt M., and Descoteaux A. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J Immunol 171 (2003) 4187-4194
54. Deb D.K., Sassano A., Lekmine F., Majchrzak B., Verma A., Kamkhampati S., et al. Activation of protein kinase C delta by IFN-gamma. J Immunol 171 (2003) 267-273
55. Chang Y.J., Holtzman M.J., and Chen C.C. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1. Mol Pharmacol 65 (2004) 589-598
56. Zhang X., Wrzeszczynska M.H., Horvath C.M., and Darnell Jr. J.E. Interacting regions in STAT3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell Biol 19 (1999) 7138-7146
57. Taniguchi T., and Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14 (2002) 111-116
58. Harada H., Kondo T., Ogawa S., Tamura T., Kitagawa M., Tanaka N., et al. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene 9 (1994) 3313-3320
59. Pine R., Canova A., and Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J 13 (1994) 158-167
60. Ramsauer K., Farlik M., Zupkovitz G., Seiser C., Kroger A., Hauser H., et al. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene. Proc Natl Acad Sci USA 104 (2007) 2849-2854
61. Kumatori A., Yang D., Suzuki S., and Nakamura M. Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene. J Biol Chem 277 (2002) 9103-9111
62. Chatterjee-Kishore M., Wright K.L., Ting J.P., and Stark G.R. How STAT1 mediates constitutive gene expression: a complex of unphosphorylated STAT1 and IRF1 supports transcription of the LMP2 gene. EMBO J 19 (2000) 4111-4122
63. Driggers P.H., Ennist D.L., Gleason S.L., Mak W.H., Marks M.S., Levi B.Z., et al. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 87 (1990) 3743-3747
64. Nelson N., Kanno Y., Hong C., Contursi C., Fujita T., Fowlkes B.J., et al. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of STAT-1 and IFN consensus sequence binding protein expression by T cell activation. J Immunol 156 (1996) 3711-3720
65. Sharf R., Meraro D., Azriel A., Thornton A.M., Ozato K., Petricoin E.F., et al. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem 272 (1997) 9785-9792
66. Dimberg A., Karehed K., Nilsson K., and Oberg F. Inhibition of monocytic differentiation by phosphorylation-deficient STAT1 is associated with impaired expression of STAT2 ICSBP/IRF8 and C/EBPepsilon. Scand J Immunol 64 (2006) 271-279
67. Chang C.H., Guerder S., Hong S.C., van Ewijk W., and Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4 (1996) 167-178
68. Nagarajan U.M., Bushey A., and Boss J.M. Modulation of gene expression by the MHC class II transactivator. J Immunol 169 (2002) 5078-5088
69. Muhlethaler-Mottet A., Di Berardino W., Otten L.A., and Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between STAT1 and USF-1. Immunity 8 (1998) 157-166
70. van den Elsen P.J., van der Stoep N., Vietor H.E., Wilson L., van Zutphen M., and Gobin S.J. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA. Hum Immunol 61 (2000) 850-862
71. Roy S.K., Wachira S.J., Weihua X., Hu J., and Kalvakolanu D.V. CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J Biol Chem 275 (2000) 12626-12632
72. Gade P., Roy S.K., Li H., Nallar S.C., and Kalvakolanu D.V. Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol 28 (2008) 2528-2548
73. Eichbaum Q.G., Iyer R., Raveh D.P., Mathieu C., and Ezekowitz R.A. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU 1 site and a transcription initiator consensus. J Exp Med 179 (1994) 1985-1996
74. Mazzi P., Donini M., Margotto D., Wientjes F., and Dusi S. IFN-gamma induces gp91phox expression in human monocytes via protein kinase C-dependent phosphorylation of PU 1. J Immunol 172 (2004) 4941-4947
75. Schroder K., Lichtinger M., Irvine K.M., Brion K., Trieu A., Ross I.L., et al. PU 1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. J Leukoc Biol 81 (2007) 1577-1590
76. Kautz B., Kakar R., David E., and Eklund E.A. SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous Cis elements in the CYBB and NCF2 genes. J Biol Chem 276 (2001) 37868-37878
77. Ramana C.V., Grammatikakis N., Chernov M., Nguyen H., Goh K.C., Williams B.R., et al. Regulation of c-myc expression by IFN-gamma through STAT1-dependent and -independent pathways. EMBO J 19 (2000) 263-272
78. Horvath C.M., and Darnell Jr. J.E. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active STAT1 protein. J Virol 70 (1996) 647-650
79. Shultz D.B., Fuller J.D., Yang Y., Sizemore N., Rani M.R., and Stark G.R. Activation of a subset of genes by IFN-gamma requires IKKbeta but not interferon-dependent activation of NF-kappaB. J Interf Cytok Res 27 (2007) 875-884
80. Sizemore N., Agarwal A., Das K., Lerner N., Sulak M., Rani S., et al. Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes. Proc Natl Acad Sci USA 101 (2004) 7994-7998 [Epub 2004 May 7917]
81. Clarke C.J., Apostolidis V., Hii L.L., Gough D.J., Trapani J.A., and Johnstone R.W. Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI 16. J Cell Biochem 89 (2003) 80-93
82. Lewis M., Amento E.P., and Unemori E.N. Transcriptional inhibition of stromelysin by interferon-gamma in normal human fibroblasts is mediated by the AP-1 domain. J Cell Biochem 72 (1999) 373-386
83. Landolfo S., Gariglio M., Gribaudo G., Jemma C., Giovarelli M., and Cavallo G. Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes. Eur J Immunol 18 (1988) 503-509
84. Liu Y., and Janeway Jr. C.A. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med 172 (1990) 1735-1739
85. Pernis A., Gupta S., Gollob K.J., Garfein E., Coffman R.L., Schindler C., et al. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 269 (1995) 245-247
86. Eilers A., Seegert D., Schindler C., Baccarini M., and Decker T. The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage. Mol Cell Biol 13 (1993) 3245-3254
87. Lee C.K., Bluyssen H.A., and Levy D.E. Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem 272 (1997) 21872-21877
88. Levy D.E., Lew D.J., Decker T., Kessler D.S., and Darnell Jr. J.E. Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J 9 (1990) 1105-1111
89. Wong L.H., Krauer K.G., Hatzinisiriou I., Estcourt M.J., Hersey P., Tam N.D., et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma. J Biol Chem 272 (1997) 28779-28785
90. Balkwill F., and Taylor-Papadimitriou J. Interferon affects both G1 and S + G2 in cells stimulated from quiescence to growth. Nature 274 (1978) 798-800
91. Xaus J., Cardo M., Valledor A.F., Soler C., Lloberas J., and Celada A. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11 (1999) 103-113
92. Ramana C.V., Gil M.P., Han Y., Ransohoff R.M., Schreiber R.D., and Stark G.R. STAT1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 98 (2001) 6674-6679
93. Platanias L.C., Uddin S., Bruno E., Korkmaz M., Ahmad S., Alsayed Y., et al. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol 27 (1999) 1315-1321
94. Navarro A., Anand-Apte B., Tanabe Y., Feldman G., and Larner A.C. A PI-3 kinase-dependent STAT1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J Leukoc Biol 73 (2003) 540-545
95. Li Q., Van Antwerp D., Mercurio F., Lee K.F., and Verma I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284 (1999) 321-325
96. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376 (1995) 167-170
97. Hilberg F., Aguzzi A., Howells N., and Wagner E.F. c-jun is essential for normal mouse development and hepatogenesis. Nature 365 (1993) 179-181
98. Horvath C.M. Weapons of STAT destruction interferon evasion by paramyxovirus V protein. Eur J Biochem 271 (2004) 4621-4628